Cargando…
Mesenchymal stem cells generate a CD4(+)CD25(+)Foxp3(+) regulatory T cell population during the differentiation process of Th1 and Th17 cells
INTRODUCTION: Mesenchymal stem cells (MSCs) are adult, multipotent, stem cells with immunomodulatory properties. The mechanisms involved in the capacity of MSCs to inhibit the proliferation of proinflammatory T lymphocytes, which appear responsible for causing autoimmune disease, have yet to be full...
Autores principales: | Luz-Crawford, Patricia, Kurte, Monica, Bravo-Alegría, Javiera, Contreras, Rafael, Nova-Lamperti, Estefania, Tejedor, Gautier, Noël, Danièle, Jorgensen, Christian, Figueroa, Fernando, Djouad, Farida, Carrión, Flavio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706898/ https://www.ncbi.nlm.nih.gov/pubmed/23734780 http://dx.doi.org/10.1186/scrt216 |
Ejemplares similares
-
Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway
por: Luz-Crawford, Patricia, et al.
Publicado: (2012) -
Mesenchymal Stem Cells Repress Th17 Molecular Program through the PD-1 Pathway
por: Luz-Crawford, Patricia, et al.
Publicado: (2012) -
IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis
por: Kurte, Mónica, et al.
Publicado: (2018) -
Time-dependent LPS exposure commands MSC immunoplasticity through TLR4 activation leading to opposite therapeutic outcome in EAE
por: Kurte, Mónica, et al.
Publicado: (2020) -
Gilz-Activin A as a Novel Signaling Axis Orchestrating Mesenchymal Stem Cell and Th17 Cell Interplay
por: Luz-Crawford, Patricia, et al.
Publicado: (2018)